Quantitative susceptibility mapping (QSM) aims to evaluate the distribution of magnetic susceptibility from magnetic resonance phase measurements by solving the ill-conditioned dipole inversion problem. Removing the artifacts and preserving the anisotropy of tissue susceptibility simultaneously is still a challenge in QSM. To deal with this issue, a novel k-QSM network is proposed to resolve dipole inversion issues in QSM reconstruction. The k-QSM network converts the results obtained by truncated k-space division (TKD) into the Fourier domain as inputs. After passing through several convolutional and residual blocks, the ill-posed signals of TKD are corrected by making the network output close to the calculation of susceptibility through multiple orientation sampling (COSMOS)-labeled QSM. To evaluate the superiority of k-QSM, comparisons with several state-of-the-art methods are performed in terms of QSM artifacts removing, anisotropy preserving, generalization ability, and clinical applications. Compared to existing methods, the k-QSM achieves a 22.31% lower normalized root mean square error, 10.30% higher peak signal-to-noise ratio (PSNR), 33.10% lower high-frequency error norm, and 1.06% higher structural similarity. In addition, the orientation-dependent susceptibility variation obtained by k-QSM is significant, verifying that k-QSM has the ability to preserve susceptibility anisotropy. When the trained models are tested on the dataset from different centers, our k-QSM shows a strong generalization ability with the highest PSNR. Moreover, by comparing the susceptibility maps between healthy controls and drug addicts with different methods, we found the proposed k-QSM is more sensitive to the susceptibility abnormality in the patients. The proposed k-QSM method learns less—only to fix the ill-posed signals of TKD, but infers more—both COSMOS-like and anisotropy-preserving QSM results. Its generalization ability and great sensitivity to susceptibility changes can make it a potential method for distinguishing some diseases.